Indaptus Therapeutics, Inc. INDP Q4 2025 Annual earnings
Reported March 17, 2026 · Before market open
EPS estimate-$4.36
Next report
Aug 17, 2026 (in a month)EPS estimate-$1.57
Versus estimates
Diluted EPS
Ask the moment Indaptus Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Indaptus Therapeutics, Inc. report Q4 2025 earnings?
- Indaptus Therapeutics, Inc. (INDP) reported Q4 2025 earnings on March 17, 2026 before market open.
- What were Indaptus Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Indaptus Therapeutics, Inc. reported diluted EPS of $-3.10 for Q4 2025.
- Did Indaptus Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-4.36 by $1.26.
- How did Indaptus Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 715.8% from $-0.38.
- Where can I find Indaptus Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-010585) directly on SEC EDGAR. The filing index links above go to sec.gov.